Postbiotics Market to Reach US$ 235.9 Mn by 2031, Growing at 9.5% CAGR as Shelf-Stable Formats and GLP-1 Companion Nutrition Expand: New Report by Wissen Research

SHERIDAN, Wyo., Oct. 9, 2026 /PRNewswire/ —

What is the postbiotics market worth, and why is it growing? 

The global postbiotics market is valued at USD 150 million in 2026 and is projected to reach USD 235.9 million by 2031, growing at a CAGR of 9.5% over the forecast period (2026–2031), according to a new study by Wissen Research.

Postbiotics are preparations of inanimate microorganisms and/or their components, including microbial cells, cell fractions, and metabolites, that provide a demonstrated health benefit. Because they contain no live cultures, they remain stable through food processing and at room temperature, which lets brands move gut-health and immune-support products out of the cold chain and into ambient supplements, snack bars, and beverages where live probiotics struggle to survive.

Get a Free Sample of This Report to Explore Key Findings and Data: https://www.wissenresearch.com/request-a-sample/?report=postbiotics-market 

Shelf-Stable by Design: Why Postbiotics Are Moving Out of the Cold Chain

The commercial case for postbiotics starts with manufacturing. Inactivated cultures can withstand the heat, storage, and processing conditions that normally destroy live strains, so shelf-stable formulations no longer depend on cold-chain distribution. That opens up dairy, bakery, beverage, and supplement formats, including synbiotic gummies that combine postbiotics with prebiotics and probiotics.

Scientific alignment is helping too. The 2021 ISAPP consensus definition gave researchers and companies a common reference point that separates postbiotics from probiotics and prebiotics, although regulatory pathways and health-claim requirements still vary by region. Enabling technologies such as precision fermentation, multi-omics profiling, and encapsulation are improving how targeted microbial fractions and metabolites are produced, characterized, and delivered, while AI-based strain identification and formulation tools remain at an early stage.

GLP-1 Companion Nutrition: A New Commercial Opportunity

The rapid uptake of GLP-1 medications for weight loss is creating a companion nutrition category focused on preserving lean mass, sustaining weight loss, and addressing nutrient gaps during rapid weight loss. Postbiotic suppliers are positioning themselves in this space, and consumer brands are exploring metabolic-health and weight-management formulations. Early research interest is growing, although clinical evidence specifically combining postbiotics with GLP-1 therapies remains limited, so claims in this area depend on further substantiation.

What’s Fueling Growth in the Postbiotics Market

• Shelf-Stability Advantage: Inactivated cultures survive conventional processing and storage, enabling ambient products without cold-chain distribution.
• Common Scientific Framework: The 2021 ISAPP definition has improved consistency in research, product development, and industry communication.
• Expanding Evidence on Short-Chain Fatty Acids: Growing research on short-chain fatty acids as systemic signaling molecules supports claims in immune and metabolic regulation beyond digestive health.
• GLP-1 Companion Nutrition: A new category built around nutrition support during weight management is opening opportunities for postbiotic suppliers.
• Pet Nutrition Crossover: Pet food companies are adopting human microbiome trends through postbiotic and synbiotic formulations for digestive and metabolic health.
• Personal Care Expansion: Postbiotic fractions such as exopolysaccharides are being used in skin and scalp barrier products, extending the category from ingestibles to topicals.

Challenges Facing the Postbiotics Market

The absence of a harmonized global regulatory framework specific to postbiotics is the industry’s biggest structural limitation. Companies must navigate existing food, supplement, novel food, and health-claim rules that differ by geography, which creates uncertainty about permissible claims and ingredient classification and raises compliance risk when entering international markets.

Analytical standardization is a second hurdle. Postbiotic products range from whole attenuated cells to specific metabolites, and characterizing these multi-component preparations consistently is methodologically difficult. That complicates quality control, comparison across studies, and the uniform labeling that regulators and retailers want.

Recent Strategic Developments in the Postbiotics Market

In August 2026, The Akkermansia Company, a Danone subsidiary based in Belgium, launched METAbiotics in the United States, a consumer postbiotic based on Akkermansia muciniphila research and positioned around weight management and metabolic health.

Also in August 2026, Superbrewed Food of the United States announced the commercial launch of Thryvia, a stable protein-based postbiotic aimed at digestive and immune health, with potential use across supplements, foods, and beverages.

In May 2026, Probi of Sweden introduced Rham271h at Vitafoods Europe 2026, a heat-inactivated form of Lacticaseibacillus rhamnosus 271 designed for functional food and beverage products with immune-support claims.

In May 2025, Lallemand Health Solutions of Canada and Kirin Holdings of Japan signed an agreement to broaden the global reach of IMMUSE, a heat-inactivated Lactococcus lactis postbiotic developed by Kirin for immune health, combining Lallemand’s formulation and commercialization capabilities with Kirin’s research expertise.

These moves show specialist developers and established ingredient companies competing on strain-specific science, immune and metabolic positioning, and partnerships for geographic reach.

Key Insights from Postbiotics Market Analysis

• Bacteria-derived postbiotics held the largest share by source in 2025, reflecting the maturity of bacterial fermentation inherited from the probiotics industry, which lowers the barrier to converting existing production lines.
• Dietary supplements remain the leading commercial application, with functional food and beverages expected to see considerable growth as heat stability allows products without live cultures.
• North America held the largest regional share in 2025, supported by strong consumer awareness of gut health and immunity and active ingredient innovation, with several 2026 launches debuting in the region first.
• Asia Pacific is the fastest-growing region, driven by rising disposable income, growing gut-health awareness, and rising use of functional foods and supplements, with China and India still largely untapped.
• The market is fragmented. Large companies defend their positions through fermentation technology and probiotic customer relationships, while specialists compete on strain- and metabolite-specific evidence.

Key Players in the Postbiotics Market

Leading companies in the postbiotics market compete on strain and metabolite specificity, depth of clinical documentation, formulation flexibility, and speed of geographic expansion through distribution partnerships.

Regional Analysis and Growth Opportunities

North America leads the postbiotics market, backed by strong consumer awareness of gut health and immunity products and active ingredient innovation and commercialization. The region is also where new postbiotic products tend to launch first, particularly in weight-management and digestive-health supplements.

Asia Pacific is the fastest-growing region, supported by higher disposable incomes, growing gut-health awareness, and wider use of functional foods and supplements. South Korea already shows postbiotic commercialization activity in adjacent nutrition and pharmaceutical areas, while China and India offer largely untapped markets with rising health spending.

Europe, Latin America, and the Middle East & Africa complete the report’s regional coverage.

Get a Custom Briefing on This Market for Your Business

Wissen Research’s analysts are available to walk through findings specific to your market, region, or competitive set.

Need Insights Specific to Your Business? Request a Customized Version of This Report: https://www.wissenresearch.com/request-customization/?report=postbiotics-market 

Market Segmentation Snapshot

The global postbiotics market is segmented across source, type, form, application, distribution channel, end user, and region:

• By Source:
  • Bacteria-Derived (Lactobacillus, Bifidobacterium, Akkermansia, Other Strains)
  • Yeast-Derived (Saccharomyces, Other Yeast Strains)
  • Other
• By Type:
  • Inactivated Whole Microorganisms (Heat-Killed Bacteria, Yeast Preparations, Paraprobiotic Preparations)
  • Cell Components & Lysates (Cell Wall Fragments, Peptidoglycan, Teichoic Acids, Membrane Components)
  • Microbial-Derived Metabolites (Short-Chain Fatty Acids, Organic Acids, Bioactive Peptides, Vitamins, Exopolysaccharides)
  • Bioactive Microbial Compounds (Bacteriocins, Enzymes, Antimicrobial Compounds)
  • Other
• By Form:
  • Powder
  • Capsules
  • Tablets
  • Liquid/Drops
  • Gummies
  • Gels/Creams
  • Sprays
  • Encapsulated
  • Other
• By Application:
  • Dietary Supplements
  • Functional Food & Beverages
  • Infant Nutrition
  • Animal Feed & Pet Nutrition
  • Cosmetics & Personal Care
  • Pharmaceuticals & Clinical Nutrition
  • Sports & Performance Nutrition
  • Other
• By Distribution Channel:
  • Online Retail/E-Commerce
  • Pharmacies & Drug Stores
  • Supermarkets/Hypermarkets
  • Direct Sales/Practitioner Channels
  • Others
• By End User:
  • Human
  • Animal
  • Other
• By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

Q: What is the size of the postbiotics market? A: The global postbiotics market is estimated at USD 150 million in 2026 and is projected to reach USD 235.9 million by 2031.

Q: What is the growth rate of the postbiotics market? A: The postbiotics market is projected to grow at a CAGR of 9.5% between 2026 and 2031.

Q: What are postbiotics, and how do they differ from probiotics? A: Postbiotics are preparations of inanimate microorganisms and/or their components, including microbial cells, cell fractions, and metabolites, that provide a demonstrated health benefit. Unlike probiotics, they contain no live organisms, which makes them stable through food processing and at room temperature.

Q: Which source of postbiotics holds the largest market share? A: Bacteria-derived postbiotics held the largest share by source in 2025, reflecting the maturity of bacterial fermentation processes established in the probiotics industry.

Q: Which application leads the postbiotics market? A: Dietary supplements remain the leading commercial application, with functional food and beverages expected to see considerable growth during the forecast period.

Q: Which region leads the postbiotics market? A: North America held the largest share of the postbiotics market in 2025, while Asia Pacific is the fastest-growing region through 2031.

Q: Who are the key players in the postbiotics market? A: Leading companies in the postbiotics market include ADM, Cargill, Kerry Group, dsm-firmenich, BASF, and Novonesis.

As shelf-stable formats, immune and metabolic health claims, and GLP-1 companion nutrition continue to expand, postbiotics are moving from a niche microbiome ingredient toward a defined functional category. For ingredient developers and brands, the path forward lies in strain- and metabolite-specific clinical evidence, regulatory clarity, and partnerships that extend geographic reach.

Get the Complete Postbiotics Market Report — Forecasts, Insights & Growth Opportunities: https://www.wissenresearch.com/market-research-reports-pricings/postbiotics-market 

Expert Profile | Mayur Jain, Wissen Research 
Mayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry. 

Email: mayur@wissenresearch.com
LinkedIn:  https://www.linkedin.com/in/mayur-jain-0190542a/ 

About Wissen Research

Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets

Company Contact:

Wissen Research LLC,
Gould St, Ste R,
Sheridan, WY 82801,
Phone: (+1) 510 240 9853
Email: info@wissenresearch.com
Website: https://www.wissenresearch.com/
Blog: https://www.wissenresearch.com/insights/
LinkedIn: https://www.linkedin.com/company/wissen-research 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/postbiotics-market-to-reach-us-235-9-mn-by-2031–growing-at-9-5-cagr-as-shelf-stable-formats-and-glp-1-companion-nutrition-expand-new-report-by-wissen-research-302903632.html